HealthcareFDA's limitations on J&J vaccine haven't disrupted providers

FDA’s limitations on J&J vaccine haven’t disrupted providers


The Food and Drug Administration’s decision to limit the use of the Johnson & Johnson COVID-19 vaccine won’t have a significant impact on health systems.

The FDA scaled back the emergency use authorization of the vaccine developed by J&J and its Janssen Pharmaceuicals subsidiary because it caused a rare blood clotting disorder in 60 patients out of 18.7 million doses administered. The vaccine should only be used for adults who would otherwise go unvaccinated or who cannot have the Pfizer and Moderna vaccines, the agency said.

Most patients received Pfizer and Moderna’s mRNA vaccines and providers have stored minimal amounts of the J&J vaccine, several health systems said. The J&J shot only accounts for about 3.4% of the 578 million doses of the COVID-19 vaccine administered, according to Centers for Disease Control and Prevention data.

None of Yale New Haven Health’s patients experienced any serious side effects from the J&J vaccine, and most went on to get a mRNA booster, said Dr. Ohm Deshpande, vice president of population health & clinical financial services at Yale New Haven Health.

“We have not received any significant feedback since the FDA’s most recent admission,” she wrote in an email, adding that the health system has worked closely with patients who received the J&J vaccine as new data comes to light. Yale New Haven Health did not have data regarding whether patients who received the J&J vaccine received more follow-up care than those who received Pfizer’s or Moderna’s.

Both Yale New Haven Health and University of Utah Health have kept minimal amounts of the J&J vaccine on hand.

The J&J vaccine has been difficult to obtain, which has likely limited its distribution across the healthcare supply chain, said Erin Fox, senior pharmacy director at University of Utah Health.



Original Source Link

Latest News

This Dog Is So Old!

Yes! Teddy Hilton turns SEVENTEEN in August!!!! The post This Dog Is So Old! appeared first on Perez Hilton. Original...

The most useful leadership book you’ve never read

Published more than 20 years ago, under a title that would not likely make it past today’s editorial...

Standard Chartered is Building a Bitcoin Trading Desk

Global banking giant Standard Chartered is launching a spot trading desk for Bitcoin and ether, positioning itself as...

Hitting defence targets is not as simple as money

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly...

Even Elden Ring’s game director knows Erdtree is too hard

As I work my way through Shadow of the Erdtree, the new DLC for Elden Ring, I can’t...

No First Amendment Protection for “Shouting into a Bullhorn and Blaring the Bullhorn’s Siren as Close as Three Feet from Government Employees …

From People v. Rolfe, decided Tuesday by the Appellate Court of Illinois, in an opinion by Justice James...

Must Read

Why is Fisker bankrupt? Weak EV market aside, the embattled Tesla rival faced big challenges

Henrik Fisker’s latest venture has been marred by...

U.S. Removing Its Pier From Gaza Coast Again Due To Weather

WASHINGTON (AP) — The U.S.-built pier to bring...
- Advertisement -

You might also likeRELATED
Recommended to you